4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-021972
Chief Executive Officer sold 7,800 shares at an average $38.66 ($301,546)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-28 | Sale | −2,000 | $36.75 | $73,500 | 325,737 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-28 | Sale | −1,600 | $38.02 | $60,832 | 324,137 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-28 | Sale | −300 | $38.59 | $11,577 | 323,837 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-29 | Sale | −3,700 | $39.81 | $147,297 | 320,137 | I: show line 4 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-29 | Sale | −200 | $41.70 | $8,340 | 319,937 | I: show line 5 in the form |
| Open-market sales · 7,800 sh · avg $38.66 · $301,546 | |||||||
Loading xslF345X03/doc4.xml…